Moderna slashes research spending, trims pipeline as it looks to regain footing 

Moderna Inc. on Thursday touted progress toward new vaccine approvals but said it will rein in its research and development spending and trim its pipeline as it looks to shake off the doldrums of a dwindling COVID vaccine market.